Pembrolizumab Shows Promising Results in Different Types of Tumors
News
During the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain, data from different studies assessing pembrolizumab in several types of cancer showed promising activity and safety profiles. ... Read more